Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000114

Chief Legal Officer sold 9,870 shares at $25.01 ($246,843)

  • Chief Legal Officer acquired 9,870 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · Chief Legal Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-26 Exercise or conversion : show line 1 in the form 10b5-1 +4,463 $1.86 $8,301 29,055 D
2024-08-26 Exercise or conversion : show line 2 in the form 10b5-1 +5,407 $9.57 $51,745 34,462 D
2024-08-26 Sale : show line 3 in the form 10b5-1 −9,870 $25.01 $246,843 24,592 D
Open-market sales · 9,870 sh · avg $25.01 · $246,843

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-08-26 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (right to buy) −4,463 5,537 D
2024-08-26 Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) −5,407 106,259 D
Loading xslF345X05/wk-form4_1724711007.xml…